| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519923A1 Novel benzimidazol-2-one derivatives and their use |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 03/31/2005 | WO2005028448A1 Benzyl-benzimidazolyl derivatives |
| 03/31/2005 | WO2005028447A1 Benzimidazole derivates: preparation and pharmaceutical applications |
| 03/31/2005 | WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | WO2005002520A3 Ophthalmic compositions for treating ocular hypertension |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | US20050070555 Aroyl pyridinones |
| 03/31/2005 | US20050070550 Benzoimidazole compounds |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2539766A1 Benzimidazole derivates: preparation and pharmaceutical applications |
| 03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/30/2005 | EP1518858A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1194971C Improved production process of 2-butyl-1, 3-diaze spiro [4, 4] nonane-1-ene-4-ketone |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/24/2005 | WO2004103282A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
| 03/24/2005 | WO2004007500A8 Novel diketopyrrolopyrrole pigments |
| 03/24/2005 | US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/23/2005 | EP1515956A1 Peptide deformylase inhibitors |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515694A1 Benzoxazole and benzodiazole uv-a sunscreens |
| 03/23/2005 | CN1599725A Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1597670A Organic chromophore compound and application |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 03/17/2005 | WO2004100875A3 Benzimidazoles, compositions containing such compounds and methods of use |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | DE10337993A1 Aminobenzimidazole Aminobenzimidazoles |
| 03/17/2005 | DE10337942A1 Aminobenzimidazolderivate Aminobenzimidazolderivate |
| 03/17/2005 | CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1193024C Process for producing optically active sulfoxide devivative' |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867222 Nociceptin analogs |
| 03/15/2005 | US6867209 Indole-type derivatives as inhibitors of p38 kinase |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/15/2005 | US6867200 Anticancer agents; anticoagulants |
| 03/10/2005 | WO2005021547A2 Heterocyclic cannabinoid cb2 receptor antagonists |
| 03/10/2005 | WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | US20050054705 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 03/10/2005 | US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050053871 sulpho-benzimidazole compounds; their use enhances the adhesion of hydrophilic layers to hydrophobic supports, they have no photographically active impurities and are compatible with image-wise heating with a thermal head |
| 03/10/2005 | CA2535896A1 N-substituted benzimidazolyl c-kit inhibitors |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
| 03/09/2005 | EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems |
| 03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864275 Anticancer agents; viricides |
| 03/03/2005 | WO2005019396A1 Reactions products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 03/03/2005 | WO2005019216A1 Aminobenzimidazole derivatives |
| 03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 03/03/2005 | WO2005019186A1 2-aminobenzimidazole derivatives for use in the treatment of hiv/aids |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005018568A2 Inhibitors of cathepsin s |
| 03/03/2005 | WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/03/2005 | WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/03/2005 | WO2004100525A3 System and method for blocking television signal having multiple different content ratings |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049290 Benzimidazole derivatives and their use as gnrh antagonists |
| 03/03/2005 | CA2536095A1 Aminobenzimidazole derivatives |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509517A2 Novel synthesis of irbesartan |